美国 · 平台与数据 · Yahoo Finance

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

来源：Yahoo Finance · 美国 8 小时前

The presentation will provide congress attendees, clinical investigators, members of the neuro-ophthalmology and multiple sclerosis communities with an opportunity to hear…

在 Yahoo Finance 阅读全文登录后可收藏

MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (finance.yahoo.com)

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

推荐阅读

Prediction: These 3 Stocks Will 10X in the Next 20 Years

The AES Corporation (NYSE:AES) Stock Has Consensus Target Price of $15.83

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand

Oculis to Present Late-Breaking Phase 2 ACUITY Biomarker Analyses of Privosegtor in Optic Neuritis at the 10th Joint ACTRIMS-ECTRIMS Meeting

分享

推荐阅读

Prediction: These 3 Stocks Will 10X in the Next 20 Years

The AES Corporation (NYSE:AES) Stock Has Consensus Target Price of $15.83

Nvidia to back four German AI startups as part of near-$10B European push

The world’s finance chiefs see new risks — and less China angst

Peloton COO Kirol sells $153,765 of company stock

Japan's 20-Year Government Bond Auction Draws Record Demand